Biogen has discontinued all gene therapy programs using adeno-associated virus (AAV) capsids, instead shifting resources to modalities that have the highest likelihood of achieving better treatment ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Gene Sauerwine, Jr., 45 of Wilkes-Barre, passed away at home after a lengthy illness on Sunday, September 21, 2025. Gene is already deeply missed by his parents Eugene and Cathy (Williamson) Sauerwine ...

A new gene therapy has slowed the progression of Huntington's disease by as much as 75%. Known as AMT-130, it is delivered via brain surgery, and a single dose is expected to last someone's whole life ...

Gene have returned to the stage for their first live show in 21 years – check out the footage and full setlist below. The Britpop band played a 25-song setlist at the Brudenell Social Club in Leeds ...

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...

Researchers at Tel Aviv University say they have found an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction, providing hope for a cure to ...

Researchers in the UK say clinical trials conducted on a small number of people show that a new gene therapy has slowed the progression of Huntington's disease, a fatal neurological condition. The ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...

DALLAS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus ...